Q-linea AB (publ) logo

Q-linea AB (publ)

SSE:QLINEA.ST

Overview | Financials
Company Name Q-linea AB (publ)
Symbol QLINEA.ST
Currency SEK
Price 2.49
Market Cap 290,925,445
Dividend Yield 0%
52-week-range 2.4 - 11.2
Industry Medical Instruments & Supplies
Sector Healthcare
CEO Dr. Jonas Jarvius Ph.D.
Website https://www.qlinea.com

An error occurred while fetching data.

About Q-linea AB (publ)

Q-linea AB (publ) engages in the development of instruments and consumables for infection diagnostics in Sweden. It offers inventive systems for in vitro diagnostics systems for infectious diseases. The company's lead product candidate is ASTar, an antibiotic susceptibility testing system used for positive blood cultures. It develops and delivers solutions

Related Stocks

Humana AB (publ) logo

Humana AB (publ)

HUM.ST

27 SEK

Elos Medtech AB (publ) logo

Elos Medtech AB (publ)

ELOS-B.ST

203 SEK

BioInvent International AB (publ) logo

BioInvent International AB (publ)

BINV.ST

16.58 SEK

RaySearch Laboratories AB (publ) logo

RaySearch Laboratories AB (publ)

RAY-B.ST

92.2 SEK

Hansa Biopharma AB (publ) logo

Hansa Biopharma AB (publ)

HNSA.ST

32.64 SEK

Vicore Pharma Holding AB (publ) logo

Vicore Pharma Holding AB (publ)

VICO.ST

14.38 SEK

Intervacc AB (publ) logo

Intervacc AB (publ)

IVACC.ST

3.735 SEK

IRLAB Therapeutics AB (publ) logo

IRLAB Therapeutics AB (publ)

IRLAB-A.ST

14.45 SEK

Doxa AB (publ) logo

Doxa AB (publ)

DOXA.ST

3.2 SEK

Financials

Numbers are in millions USD

Numbers are in millions USD